THE CLINICAL DEVELOPMENT OF CARFILZOMIB

Carfilzomib is a second-generation proteasome inhibitor that is being investigated as a potential treatment for patients .

#Website #More

THE CLINICAL DEVELOPMENT OF CARFILZOMIB

Industry:
Biotechnology Health Care

Founded:
1992-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.onyx.com

Total Employee:
10001+

Status:
Active

Contact:
6502660784

Email Addresses:
[email protected]

Technology used in webpage:
Domain Not Resolving IPv6 Microsoft CPanel SSL MailChimp CPanel OVH Apple Whitelist


Official Site Inspections

http://www.onyx.com

  • Host name: a16e665f42988324c.awsglobalaccelerator.com
  • IP address: 76.223.105.230
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "The Clinical Development of Carfilzomib" on Search Engine